This I D Cancer Center guide explains what PSA is, why it rises, what your PSA report may mean, and how we typically plan the next steps (repeat PSA, MRI, and—when needed—biopsy), in a patient-friendly way.

What is Serum PSA?

Serum PSA is a blood test that measures the level of PSA—a protein produced mainly by the prostate gland. A small amount normally enters the bloodstream. PSA levels can increase when the prostate is enlarged, inflamed, infected, or affected by cancer.

Why PSA is important in prostate cancer

Prostate cancer varies widely:

• Many prostate cancers are slow-growing and may be safely monitored in selected patients.

• Some are aggressive and benefit from early diagnosis and timely treatment.

PSA helps identify:

• who needs further evaluation

• who may benefit from MRI and/or biopsy

• who may be suitable for active surveillance vs active treatment

Common reasons PSA can rise (not only cancer)

PSA can increase due to:

• Benign Prostatic Hyperplasia (BPH): enlarged prostate (very common with age)

• Prostatitis (prostate inflammation) or urinary infection

• Recent ejaculation

• Cycling / prolonged perineal pressure

• Recent catheterization or urinary procedures

• Prostate cancer

Key point: A raised PSA does not automatically mean cancer.

“Normal PSA” vs “High PSA”: why one number is not enough

There is no single PSA value that is “perfectly normal” for everyone. Interpretation depends on:

1) Age

PSA tends to rise with age due to prostate enlargement.

2) Prostate size (volume)

A larger benign prostate can produce more PSA. This is why clinicians often consider PSA density (PSA ÷ prostate volume).

3) PSA trend over time

A single PSA value is less informative than repeat PSA and trend.

4) Symptoms + examination

Urinary symptoms (weak stream, frequency, nocturia) are common in BPH. They warrant evaluation, but they are not proof of cancer.

Before you repeat the test: how to prepare for PSA (practical checklist)

To reduce “false alarms,” we usually advise:

• Avoid ejaculation for ~48 hours before PSA testing

• Avoid cycling/heavy perineal pressure for ~48 hours

• If you have burning urine/fever or suspected UTI, treat first and test after recovery (as guided by your doctor)

• Tell your clinician about medicines—especially finasteride/dutasteride, which can lower PSA and require adjusted interpretation

(Your treating doctor may personalize these instructions.)

What happens at I D Cancer Center after a raised PSA?

A raised PSA usually triggers a step-wise risk assessment, not instant biopsy for everyone.

Step 1: Confirm and contextualize

• Review symptoms, medical history, family history

• Check if anything could temporarily raise PSA

• Repeat PSA when appropriate (often the first step)

Step 2: Clinical evaluation

• Physical examination including DRE (Digital Rectal Examination) if indicated

Step 3: Risk refinement tests (case-dependent)

Depending on your case, we may consider:

• % Free PSA

• PSA density (requires ultrasound/MRI prostate volume)

• Other biomarker tests (availability varies)

Step 4: Multiparametric MRI (mpMRI) prostate

If PSA remains concerning, MRI prostate is a key modern tool. It helps:

• find suspicious lesions

• reduce unnecessary biopsies in selected cases

• guide targeted biopsy for higher accuracy

Step 5: Prostate biopsy (only when needed)

Biopsy is advised if risk is significant based on PSA + exam + MRI (and other factors). Many centers now use MRI-guided targeting along with systematic sampling depending on scenario.

PSA Screening: who should consider it?

PSA screening is best approached via shared decision-making—balancing benefit (early detection of significant cancers) against harms (false positives, anxiety, unnecessary biopsy, overdiagnosis).

At I D Cancer Center, we recommend discussing PSA screening if you are:

• Typically 50+ years, or earlier if higher risk

• Have a strong family history (father/brother with prostate cancer)

• Have persistent urinary symptoms, or an abnormal DRE, or prior concerning PSA trend

Important: Screening decisions should be individualized based on age, life expectancy, comorbidities, and preferences.

Frequently asked questions (FAQ)

1) If my PSA is high, do I definitely have cancer?

No. PSA can rise due to BPH or infection/inflammation. A high PSA means higher probability, not a diagnosis.

2) If my PSA is normal, am I completely safe?

Not completely. PSA is an important marker, but not perfect. Risk assessment includes symptoms, exam, and sometimes imaging.

3) Should I do MRI before biopsy?

Often, yes—MRI first is increasingly used because it can improve risk stratification and help target biopsy. The best sequence depends on your case.

4) What PSA level is “dangerous”?

Risk is not determined by one cutoff. We interpret PSA using age, trend, prostate size, symptoms, and MRI findings.

When you should seek urgent evaluation

Seek medical attention promptly if you have:

• Fever with urinary symptoms (possible infection)

• Inability to pass urine (urinary retention)

• Blood in urine

• Severe bone pain, unexplained weight loss, or marked fatigue (especially with significantly raised PSA)

How prostate cancer is treated (if diagnosed)

Treatment is personalized based on stage, risk group, and patient goals. Options can include:

• Active surveillance (for low-risk cancers in suitable patients)

• Surgery (radical prostatectomy in selected cases)

• Radiotherapy (e.g., IMRT/VMAT with image guidance)

• Hormonal therapy (ADT) in appropriate settings

• Systemic therapies for advanced disease as needed

At I D Cancer Center, our goal is to match the treatment intensity to the cancer’s biology—avoiding overtreatment while not missing aggressive disease.

Take-home message

• PSA is a useful risk marker, not a cancer diagnosis.

• A single high value often needs repeat testing and context.

• Modern evaluation commonly includes MRI-based risk assessment.

• Decisions on biopsy and treatment should be personalized.

Book a consultation / Second Opinion (I D Cancer Center)

If you have a raised PSA report, ongoing urinary symptoms, or concerns about prostate cancer, you can consult our team for a structured evaluation plan.